跳至主要内容
临床试验/CTRI/2017/09/009691
CTRI/2017/09/009691尚未招募3 期

The efficacy and safety of Clomipramine Hydrochloride versus Dapoxetine Hydrochloride in Married Heterosexual Men with Premature Ejaculation: A Pragmatic, Randomized Controlled Trial.

Christian Medical College0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Married male
  • Has active and stable sexual relationship with wife
  • Age â?? 21 to 64 years
  • Meets DSM-5 criteria for premature ejaculation after screening
  • Heterosexual orientation
  • Speaks either of these languages â?? Hindi, Bengali, English, Tamil, Telugu, Malayalam
  • Agrees to have sexual intercourse at least once a week (or at least six times) over the study period
  • Agrees not to use study medicines more than once a day

排除标准

  • Comorbid major mental illness (Psychosis, Bipolar affective disorder, Major Depressive Disorder, Obsessive compulsive disorder);
  • Active psychoactive substance use in dependence pattern (other than Nicotine);
  • Uncontrolled or Untreated medical comorbidities (Diabetes, Hypertension, Hypothyroidism, Cardiac illness, renal disease);
  • Current use of antipsychotic and antidepressant drugs, herbal medicines, phosphodiesterase type 5 inhibitors (for example, sildenafil);
  • Use of either Dapoxetine or Clomipramine in the past;
  • Any potential neurological, urological, or endocrine cause of PE;
  • Scoring 3 or 4 on first two domains, 0 or 1 on the third domain, and 0 on the fourth domain of the Premature Ejaculation Profile (PEP);

研究者

相似试验